Isis Lunsky

Isis Lunsky

Auto-generated profile, based on publicly available information

Isis Lunsky

Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Journal of Psychoactive Drugs
Verified
Journal Article
Closed access
ABAnees Bahji
Anees Bahji
ILIsis Lunsky
Isis Lunsky
GGGilmar Gutierrez
Gilmar Gutierrez
GVGustavo H Vazquez
Gustavo H Vazquez
There has been a resurgence in psychedelic research for managing psychiatric conditions in recent years. This study aimed to present a comprehensive review of the current state of the field by applying a systematic search strategy for articles on the effectiveness and tolerability of four psychedelic-assisted therapies (psilocybin, lysergic acid diethylamide [LSD], 3,4-Methylenedioxymethamphetamine [MDMA], and ayahuasca) for adults with symptoms of depression, anxiety, and posttraumatic stress disorder (PTSD). Psychometric scores and adverse events were pooled using random-effects meta-analysis models with Hedges' g bias-corrected standardized mean differences (g) and rate ratios (RR) with 95% confidence intervals (CI). Bias evaluation followed PRISMA and Cochrane guidelines. Eighteen studies were identified, which suggested that psychedelic therapies were well tolerated and presented a large effect size for the management of depression symptoms in a transdiagnostic population with psilocybin (g = -1.92, 95% CI, -2.73 to -1.11) and MDMA (g = -0.71; 95% CI, -1.39 to -0.03). These are promising results that complement the current literature. However, evidence certainty was low to very low due to methodological limitations, small sample size, blinding, study heterogeneity, and publication bias. These results also highlight the need for more adequately powered studies exploring these novel therapies.

5 June 2025 in HPB
Verified
Journal Article
Open access
VWVanessa Wiseman
Vanessa Wiseman
JMJonah Moore
Jonah Moore
SMSandra McKeown
Sandra McKeown
ILIsis Lunsky
Isis Lunsky
JFJennifer Flemming
Jennifer Flemming
SBSean Bennett
Sean Bennett
Patients with cirrhosis are at increased risk of gallstone disease. The objective of this review was to assess the literature to better define the perioperative risks for patients with cirrhosis undergoing laparoscopic cholecystectomy. A systematic review was conducted using PRISMA guidelines. Inclusion criteria included papers published since 1990, with at least 25 patients with cirrhosis undergoing cholecystectomy. Outcomes of interest were post-operative liver decompensation, bile leak, surgical site infection (SSI), pneumonia, venous thromboembolism (VTE), transfusions and mortality. Forty-two papers were included with 24 575 patients, 48 % were female, with mean age of 53 years. Most patients were Child-Turcotte-Pugh A (74 %), followed by B (23 %), and C (3 %). Emergent cholecystectomy was performed in 28.7 % of patients. Post-operative liver decompensation occurred in 7.1 % (0.9-13.3, 95 % CI) of patients, superficial SSI in 1.1 % (0.6-1.5), organ space SSI in 3.7 % (2.0-5.5), bile leak in 0.7 % (0.2-1.1), VTE in 1.8 % (0.7-2.9), pneumonia in 1.9 % (1.2-2.6) and transfusions in 4 % (2.7-5.2). Post-operative mortality was 1.8 % (1.2-2.4). Laparoscopic cholecystectomy is safe in most patients with cirrhosis, with notably higher complication rates compared to the general population. Continued efforts to decrease rates of bile leak, post-operative liver decompensation and mortality should be encouraged.

15 March 2019 in European Urology Supplements
Verified
Journal Article
Closed access
KAKhaled Ajib
Khaled Ajib
MTM. Tjong
M. Tjong
ILI. Lunsky
I. Lunsky
GTG.H. Tan
G.H. Tan
GNG. Nason
G. Nason
GKG. Kulkarni
G. Kulkarni

12 May 2026 in Psychiatry Research
Verified
Journal Article
Open access
ILIsis Lunsky
Isis Lunsky
GGGilmar Gutierrez
Gilmar Gutierrez
XWXena Wang
Xena Wang
AZAndrea Zhuang
Andrea Zhuang
YZYanbo Zhang
Yanbo Zhang
SJSwainson Jennifer
Swainson Jennifer
Postpartum Depression (PPD) is a common condition with serious consequences for both mother and baby if left untreated. Currently, few effective strategies exist for prevention of PPD. Ketamine and Esketamine are rapid acting and potent antidepressants, and emerging evidence is showing promising results for PPD. This review searched the MEDLINE, CINAHL, PsycINFO, EMBASE, and Cochrane databases, including peer-reviewed randomized controlled trials (RCT), pilot studies, and observational studies. The articles studied the effects of ketamine or esketamine interventions on PPD prevention, when administered during pregnancy or postpartum for both c-section and vaginal deliveries. A network meta-analysis (for RCTs) and narrative synthesis (for other study designs) approach was used to analyze the effects of these treatments. Qualitative analysis employed the Cochrane risk of bias tool and the Grading of Recommendations Assessment, Development and Evaluation (GRADE). Thirty-six studies were identified, five included vaginal delivery, thirty included c-section, and one study did not specify delivery mode. The results of the network meta-analysis and the narrative synthesis suggested that ketamine and esketamine treatment were well tolerated, and may be associated with a reduced risk of developing PPD. However, it is worth highlighting that the quality of the data was low to very low, as such these results should be interpreted with caution. This review suggested that ketamine and esketamine treatment may lower PPD risk. Nevertheless, the poor quality and scarcity of the data, and the limitations presented by current psychiatric practice guidelines, highlight the need for more high-quality, adequately powered studies.